---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-036104"
form_type: "8-K"
ticker: "AIM"
cik: "0000946644"
company_name: "AIM ImmunoTech Inc."
filed_at: "2026-08-05T12:00:29+00:00"
generated_at: "2026-08-05T12:05:32.311196+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# AIM ImmunoTech terminates ATM equity distribution agreement with Maxim Group

## Summary
- Mutual termination of Equity Distribution Agreement with Maxim Group effective August 15, 2026; no penalties incurred.
- From April 2025 to July 2026, sold 3,200,736 shares for aggregate gross proceeds of approximately $2.8 million.
- No additional shares will be sold under the agreement prior to termination; company may seek alternative financing.

## SEC filing metadata
- accession: 0001493152-26-036104
- form_type: 8-K
- ticker: AIM
- cik: 0000946644
- company_name: AIM ImmunoTech Inc.
- filed_at: 2026-08-05T12:00:29+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946644/000149315226036104/0001493152-26-036104-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946644/000149315226036104/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-036104
- JSON: https://secwatch.observer/filing/0001493152-26-036104.json
- Plain text: https://secwatch.observer/filing/0001493152-26-036104.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.